CA Stock MarketDetailed Quotes

MDP Medexus Pharmaceuticals Inc

Watchlist
  • 3.050
  • +0.020+0.66%
15min DelayMarket Closed Dec 10 16:00 ET
75.19MMarket Cap25.00P/E (TTM)

Medexus Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
-13.27%26.3M
-13.54%27.28M
4.59%113.05M
-9.33%25.96M
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
Operating revenue
-13.27%26.3M
-13.54%27.28M
4.59%113.05M
-9.33%25.96M
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
Cost of revenue
-13.32%12.18M
-13.05%12.45M
11.41%53.54M
-7.04%12.66M
-2.19%12.52M
21.71%14.05M
41.72%14.32M
23.94%48.06M
34.16%13.62M
31.01%12.8M
Gross profit
-13.22%14.13M
-13.94%14.84M
-0.87%59.51M
-11.40%13.31M
-20.34%12.69M
0.83%16.28M
33.17%17.24M
58.30%60.04M
48.48%15.02M
38.54%15.93M
Operating expense
-21.20%10.03M
-15.27%10.51M
-9.35%46.73M
-14.03%10.48M
-12.13%11.13M
-7.90%12.72M
-3.76%12.4M
2.48%51.55M
12.71%12.19M
7.23%12.66M
Selling and administrative expenses
-22.64%7.96M
-16.24%8.7M
-8.84%38.44M
-12.27%8.64M
-11.95%9.12M
-8.67%10.29M
-2.85%10.39M
9.24%42.16M
20.84%9.85M
10.41%10.35M
-Selling and marketing expense
-44.64%1.61M
-28.94%2.09M
-7.13%10.58M
-19.97%2.12M
1.52%2.61M
-3.74%2.91M
-6.62%2.93M
19.78%11.39M
50.28%2.65M
25.48%2.57M
-General and administrative expense
-13.95%6.35M
-11.24%6.62M
-9.47%27.86M
-9.43%6.52M
-16.40%6.51M
-10.48%7.37M
-1.28%7.46M
5.80%30.77M
12.70%7.2M
6.20%7.78M
Research and development costs
-14.96%2.01M
-10.62%1.74M
-10.99%8.04M
-21.73%1.78M
-12.17%1.95M
-3.63%2.37M
-6.75%1.95M
-20.13%9.03M
-11.78%2.27M
-5.09%2.22M
Depreciation amortization depletion
-20.83%57K
1.72%59K
-28.90%251K
-11.76%60K
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
-Depreciation and amortization
-20.83%57K
1.72%59K
-28.90%251K
-11.76%60K
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
Operating profit
15.36%4.1M
-10.54%4.33M
50.63%12.79M
-0.07%2.83M
-52.08%1.57M
52.60%3.55M
7,834.43%4.84M
168.59%8.49M
503.28%2.83M
1,169.28%3.27M
Net non-operating interest income (expenses)
48.85%-2.16M
52.27%-2.03M
1.78%-13.36M
38.43%-2.22M
25.23%-2.66M
-28.42%-4.23M
-35.12%-4.26M
-11.31%-13.61M
-16.25%-3.61M
-12.41%-3.55M
Non-operating interest expense
-48.85%2.16M
-52.27%2.03M
-1.78%13.36M
-38.43%2.22M
-25.23%2.66M
28.42%4.23M
35.12%4.26M
11.31%13.61M
16.25%3.61M
12.41%3.55M
Other net income (expenses)
-744.97%-2.52M
-233.44%-399K
798.68%683K
-51.19%389K
143.09%293K
81.10%-298K
-80.53%299K
-99.63%76K
300.50%797K
-130.60%-680K
Gain on sale of security
81.54%-55K
-114.38%-43K
-109.83%-83K
-148.15%-377K
195.13%293K
75.06%-298K
-80.88%299K
-95.97%844K
272.47%783K
-113.66%-308K
Special income (charges)
---2.46M
---356K
199.74%766K
5,371.43%766K
--0
--0
--0
-368.29%-768K
-97.86%14K
-1,027.27%-372K
-Less:Restructuring and mergern&acquisition
--0
--356K
-315.36%-1.65M
-11,714.29%-1.65M
--0
--0
--0
148.42%768K
99.42%-14K
1,027.27%372K
-Less:Impairment of capital assets
--2.46M
----
--888K
----
----
--0
----
--0
----
----
Income before tax
40.29%-581K
114.93%1.9M
102.10%106K
8,150.00%990K
17.19%-795K
61.71%-973K
156.96%884K
-31.96%-5.04M
100.33%12K
22.83%-960K
Income tax
-675.83%-691K
-124.46%-57K
105.11%320K
103.33%228K
-147.71%-261K
-36.51%120K
251.30%233K
-565.46%-6.26M
-507.87%-6.84M
681.91%547K
Earnings from equity interest net of tax
Net income
110.06%110K
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
Net income continuous operations
110.06%110K
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
Noncontrolling interests
Net income attributable to the company
110.06%110K
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
110.06%110K
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
Diluted earnings per share
108.96%0.0045
166.67%0.08
-116.67%-0.01
-88.24%0.04
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
Basic earnings per share
108.96%0.0045
166.67%0.08
-116.67%-0.01
-88.24%0.04
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue -13.27%26.3M-13.54%27.28M4.59%113.05M-9.33%25.96M-12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M
Operating revenue -13.27%26.3M-13.54%27.28M4.59%113.05M-9.33%25.96M-12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M
Cost of revenue -13.32%12.18M-13.05%12.45M11.41%53.54M-7.04%12.66M-2.19%12.52M21.71%14.05M41.72%14.32M23.94%48.06M34.16%13.62M31.01%12.8M
Gross profit -13.22%14.13M-13.94%14.84M-0.87%59.51M-11.40%13.31M-20.34%12.69M0.83%16.28M33.17%17.24M58.30%60.04M48.48%15.02M38.54%15.93M
Operating expense -21.20%10.03M-15.27%10.51M-9.35%46.73M-14.03%10.48M-12.13%11.13M-7.90%12.72M-3.76%12.4M2.48%51.55M12.71%12.19M7.23%12.66M
Selling and administrative expenses -22.64%7.96M-16.24%8.7M-8.84%38.44M-12.27%8.64M-11.95%9.12M-8.67%10.29M-2.85%10.39M9.24%42.16M20.84%9.85M10.41%10.35M
-Selling and marketing expense -44.64%1.61M-28.94%2.09M-7.13%10.58M-19.97%2.12M1.52%2.61M-3.74%2.91M-6.62%2.93M19.78%11.39M50.28%2.65M25.48%2.57M
-General and administrative expense -13.95%6.35M-11.24%6.62M-9.47%27.86M-9.43%6.52M-16.40%6.51M-10.48%7.37M-1.28%7.46M5.80%30.77M12.70%7.2M6.20%7.78M
Research and development costs -14.96%2.01M-10.62%1.74M-10.99%8.04M-21.73%1.78M-12.17%1.95M-3.63%2.37M-6.75%1.95M-20.13%9.03M-11.78%2.27M-5.09%2.22M
Depreciation amortization depletion -20.83%57K1.72%59K-28.90%251K-11.76%60K-32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K
-Depreciation and amortization -20.83%57K1.72%59K-28.90%251K-11.76%60K-32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K
Operating profit 15.36%4.1M-10.54%4.33M50.63%12.79M-0.07%2.83M-52.08%1.57M52.60%3.55M7,834.43%4.84M168.59%8.49M503.28%2.83M1,169.28%3.27M
Net non-operating interest income (expenses) 48.85%-2.16M52.27%-2.03M1.78%-13.36M38.43%-2.22M25.23%-2.66M-28.42%-4.23M-35.12%-4.26M-11.31%-13.61M-16.25%-3.61M-12.41%-3.55M
Non-operating interest expense -48.85%2.16M-52.27%2.03M-1.78%13.36M-38.43%2.22M-25.23%2.66M28.42%4.23M35.12%4.26M11.31%13.61M16.25%3.61M12.41%3.55M
Other net income (expenses) -744.97%-2.52M-233.44%-399K798.68%683K-51.19%389K143.09%293K81.10%-298K-80.53%299K-99.63%76K300.50%797K-130.60%-680K
Gain on sale of security 81.54%-55K-114.38%-43K-109.83%-83K-148.15%-377K195.13%293K75.06%-298K-80.88%299K-95.97%844K272.47%783K-113.66%-308K
Special income (charges) ---2.46M---356K199.74%766K5,371.43%766K--0--0--0-368.29%-768K-97.86%14K-1,027.27%-372K
-Less:Restructuring and mergern&acquisition --0--356K-315.36%-1.65M-11,714.29%-1.65M--0--0--0148.42%768K99.42%-14K1,027.27%372K
-Less:Impairment of capital assets --2.46M------888K----------0------0--------
Income before tax 40.29%-581K114.93%1.9M102.10%106K8,150.00%990K17.19%-795K61.71%-973K156.96%884K-31.96%-5.04M100.33%12K22.83%-960K
Income tax -675.83%-691K-124.46%-57K105.11%320K103.33%228K-147.71%-261K-36.51%120K251.30%233K-565.46%-6.26M-507.87%-6.84M681.91%547K
Earnings from equity interest net of tax
Net income 110.06%110K200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M
Net income continuous operations 110.06%110K200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M
Noncontrolling interests
Net income attributable to the company 110.06%110K200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 110.06%110K200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M
Diluted earnings per share 108.96%0.0045166.67%0.08-116.67%-0.01-88.24%0.0471.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07
Basic earnings per share 108.96%0.0045166.67%0.08-116.67%-0.01-88.24%0.0471.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data